RWLK - リウォ―ク・ロボティクス (ReWalk Robotics Ltd)

RWLKのニュース

   ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the…
   COVID-19 Impacts: Medical Exoskeleton Market Will Accelerate at a CAGR of Almost 29% Through 2020-2024 | Focus on Development of 3D-printed Medical Exoskeletons to Boost Growth | Technavio  2020/07/24 17:15:00 Benzinga Feeds
Technavio has been monitoring the medical exoskeleton market and it is poised to grow by USD 351.68 million during 2020-2024, progressing at a CAGR of almost 29% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200724005276/en/ Technavio has announced its latest market research report titled Global Medical Exoskeleton Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request the Latest Free Sample Report on COVID-19 Impact Frequently Asked Questions- What is the incremental growth of the medical exoskeleton market during 2020-2024? The market is expected to register an incremental growth of USD 351.68 million during 2020-2024. At what rate is the market projected to grow during the forecast period?
   ReWalk Robotics News: RWLK Stock Rockets 31% on FDA Approval  2020/06/01 19:22:40 InvestorPlace
ReWalk Robotics (RWLK) news for Monday includes RWLK stock soaring higher on FDA approval for one of its powered exoskeletons.
   ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth  2020/05/19 22:08:00 RTT News
Today's Daily Dose brings you news about ADC Therapeutics' IPO; Aldeyra Therapeutics' COVID-19 drug development update; Bio-Techne's plan to ramp up COVID-19 Test Kit production; ReWalk's telehealth opportunities; after-hours movers and the latest on the number of coronavirus cases.
   ReWalk Robotics Increases Focus on Telehealth Opportunities  2020/05/19 13:01:00 Benzinga Feeds
MARLBOROUGH, Mass. , May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable exosuits for patients with limited mobility, ReWalk Robotics Ltd. ("ReWalk," "we" or the "Company") today announced a revision to the sponsored research agreement with Harvard to extend the term of the collaboration. Continuing the ongoing project until March 2023 , the research team will investigate how their novel designs for wearable exosuits may incorporate features that support the increasing demand for tele-healthcare, including remote data provision, analysis and remote physical therapy for patients with their therapists. Since 2016, ReWalk has funded a collaborative research project at the Wyss Institute for Biologically Inspired Engineering at Harvard University ("Wyss Institute"). The research is led by Conor Walsh , Ph.D., in his Harvard Biodesign Lab, a robotics research laboratory. Walsh is the Paul A. Maeder Professor of Engineering and Applied Sciences at the Harvard John A.
   ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the…
   COVID-19 Impacts: Medical Exoskeleton Market Will Accelerate at a CAGR of Almost 29% Through 2020-2024 | Focus on Development of 3D-printed Medical Exoskeletons to Boost Growth | Technavio  2020/07/24 17:15:00 Benzinga Feeds
Technavio has been monitoring the medical exoskeleton market and it is poised to grow by USD 351.68 million during 2020-2024, progressing at a CAGR of almost 29% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200724005276/en/ Technavio has announced its latest market research report titled Global Medical Exoskeleton Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request the Latest Free Sample Report on COVID-19 Impact Frequently Asked Questions- What is the incremental growth of the medical exoskeleton market during 2020-2024? The market is expected to register an incremental growth of USD 351.68 million during 2020-2024. At what rate is the market projected to grow during the forecast period?
   ReWalk Robotics News: RWLK Stock Rockets 31% on FDA Approval  2020/06/01 19:22:40 InvestorPlace
ReWalk Robotics (RWLK) news for Monday includes RWLK stock soaring higher on FDA approval for one of its powered exoskeletons.
   ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth  2020/05/19 22:08:00 RTT News
Today's Daily Dose brings you news about ADC Therapeutics' IPO; Aldeyra Therapeutics' COVID-19 drug development update; Bio-Techne's plan to ramp up COVID-19 Test Kit production; ReWalk's telehealth opportunities; after-hours movers and the latest on the number of coronavirus cases.
   ReWalk Robotics Increases Focus on Telehealth Opportunities  2020/05/19 13:01:00 Benzinga Feeds
MARLBOROUGH, Mass. , May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable exosuits for patients with limited mobility, ReWalk Robotics Ltd. ("ReWalk," "we" or the "Company") today announced a revision to the sponsored research agreement with Harvard to extend the term of the collaboration. Continuing the ongoing project until March 2023 , the research team will investigate how their novel designs for wearable exosuits may incorporate features that support the increasing demand for tele-healthcare, including remote data provision, analysis and remote physical therapy for patients with their therapists. Since 2016, ReWalk has funded a collaborative research project at the Wyss Institute for Biologically Inspired Engineering at Harvard University ("Wyss Institute"). The research is led by Conor Walsh , Ph.D., in his Harvard Biodesign Lab, a robotics research laboratory. Walsh is the Paul A. Maeder Professor of Engineering and Applied Sciences at the Harvard John A.
   ReWalk Robotics to Report Second Quarter 2020 Financial Results on August 12, 2020  2020/08/07 12:00:00 GlobeNewswire
MARLBOROUGH, Mass. BERLIN, Germany and YOKNEAM ILIT, Israel, Aug. 07, 2020 (GLOBE NEWSWIRE) -- ReWalk Robotics Ltd. (Nasdaq: RWLK) (“ReWalk” or the…
   COVID-19 Impacts: Medical Exoskeleton Market Will Accelerate at a CAGR of Almost 29% Through 2020-2024 | Focus on Development of 3D-printed Medical Exoskeletons to Boost Growth | Technavio  2020/07/24 17:15:00 Benzinga Feeds
Technavio has been monitoring the medical exoskeleton market and it is poised to grow by USD 351.68 million during 2020-2024, progressing at a CAGR of almost 29% during the forecast period. The report offers an up-to-date analysis regarding the current market scenario, latest trends and drivers, and the overall market environment. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200724005276/en/ Technavio has announced its latest market research report titled Global Medical Exoskeleton Market 2020-2024 (Graphic: Business Wire) Technavio suggests three forecast scenarios (optimistic, probable, and pessimistic) considering the impact of COVID-19. Please Request the Latest Free Sample Report on COVID-19 Impact Frequently Asked Questions- What is the incremental growth of the medical exoskeleton market during 2020-2024? The market is expected to register an incremental growth of USD 351.68 million during 2020-2024. At what rate is the market projected to grow during the forecast period?
   ReWalk Robotics News: RWLK Stock Rockets 31% on FDA Approval  2020/06/01 19:22:40 InvestorPlace
ReWalk Robotics (RWLK) news for Monday includes RWLK stock soaring higher on FDA approval for one of its powered exoskeletons.
   ADCT Closes IPO, ALDX To Provide COVID-19 Update, RWLK To Focus On Telehealth  2020/05/19 22:08:00 RTT News
Today's Daily Dose brings you news about ADC Therapeutics' IPO; Aldeyra Therapeutics' COVID-19 drug development update; Bio-Techne's plan to ramp up COVID-19 Test Kit production; ReWalk's telehealth opportunities; after-hours movers and the latest on the number of coronavirus cases.
   ReWalk Robotics Increases Focus on Telehealth Opportunities  2020/05/19 13:01:00 Benzinga Feeds
MARLBOROUGH, Mass. , May 19, 2020 /PRNewswire/ -- Four years after entering into a collaboration with researchers at Harvard University to develop wearable exosuits for patients with limited mobility, ReWalk Robotics Ltd. ("ReWalk," "we" or the "Company") today announced a revision to the sponsored research agreement with Harvard to extend the term of the collaboration. Continuing the ongoing project until March 2023 , the research team will investigate how their novel designs for wearable exosuits may incorporate features that support the increasing demand for tele-healthcare, including remote data provision, analysis and remote physical therapy for patients with their therapists. Since 2016, ReWalk has funded a collaborative research project at the Wyss Institute for Biologically Inspired Engineering at Harvard University ("Wyss Institute"). The research is led by Conor Walsh , Ph.D., in his Harvard Biodesign Lab, a robotics research laboratory. Walsh is the Paul A. Maeder Professor of Engineering and Applied Sciences at the Harvard John A.

calendar